Our mission is to advance infectious disease diagnosis and improve patient care using novel diagnostic platforms that produces rapid and accurate results from patient samples. Our versatile platforms address critical needs for current infectious disease epidemics such as tuberculosis (historically the leading cause of death from infectious disease worldwide), HIV, and COVID-19. 

Tuberculosis (TB) remains the "Top Infectious Disease Killer Worldwide" according to the World Health Organization with an estimated 1.5 million deaths and 10 million new cases every year.  HIV has claimed over 32 million lives and the WHO estimates 37.9 million people are currently living with the disease.  With ever growing global connectivity, the threat of infectious diseases and future contagions require better, more advanced detection technologies to provide much needed new tools for our healthcare providers.  

New Orleans, LA, USA

Nanopin Technologies

The New Orleans BioInnovation Center, part of a new wave of advancements in Louisiana, is at the forefront of today's biotechnology surge. As a cornerstone of Louisiana's commitment to nurturing biotechnology within the state, the Center is a technology business incubator that aims to stimulate bioscience entrepreneurship in the New Orleans area. Our mission is to assist in the development of biotechnology-related companies looking to commercialize technologies from the Greater New Orleans Area universities, including LSU Health Services Center, Tulane Health Services Center, the University of New Orleans, and Xavier University.

Connecting Louisiana Innovators & Local Talent